Stock Report

Medicamen Biotech Ltd Q2FY22 consolidated PAT at Rs. 4.22 crore

Posted On : 2021-11-06 20:26:00( TIMEZONE : IST )

MEDICAMEN BIOTECH LTD. has reported Consolidated financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 32.9965 crores during the period ended September 30, 2021 as compared to Rs. 27.6090 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. 4.2218 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 4.1513 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 3.46 for the period ended September 30, 2021 as compared to Rs. 3.40 for the period ended June 30, 2021.

Financials	Q2 FY2022	Q1 FY2022	% Change
Total Income	₹ 32.9965 crs	₹27.6090 crs	19.51%
Net Profit	₹4.2218 crs	₹4.1513 crs	1.70%
EPS	₹3.46	₹3.40	1.76%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 32.9965 crores during the period ended September 30, 2021 as compared to Rs.30.9038 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.4.2218 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.3.2236 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.3.46 for the period ended September 30, 2021 as compared to Rs.2.64 for the period ended September 30, 2020.

Financials	Q2 FY2022	Q2 FY2021	% Change
Total Income	₹ 32.9965 crs	₹30.9038 crs	6.77%
Net Profit	₹4.2218 crs	₹3.2236 crs	30.97%
EPS	₹3.46	₹2.64	31.06%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.60.6055 crores during the 6 Months period ended September 30, 2021 as compared to Rs.58.7714 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.8.3732 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.5.4677 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.6.85 for the 6 Months period ended September 30, 2021 as compared to Rs.4.48 for the 6 Months period ended September 30, 2020.

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹60.6055 crs	₹58.7714 crs	3.12%
Net Profit	₹8.3732 crs	₹5.4677 crs	53.14%
EPS	₹6.85	₹4.48	52.90%

Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs. 698.80 as compared to the previous close of Rs. 605.90. The total number of shares traded during the day was 49464 in over 2720 trades.

The stock hit an intraday high of Rs. 711.80 and intraday low of 623.50. The net turnover during the day was Rs. 34089707.00.